[Prolonged use of medroxyprogesterone acetate for contraception].
Pena Delgado
J
J
Aleman Herrera
M
M
Baez Reyes
A
A
D000152:Acne Vulgaris; D000568:Amenorrhea; D000569:Americas; D001519:Behavior; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003710:Demography; D003872:Dermatitis; D003906:Developing Countries; D004194:Disease; D005193:Family Planning Services; D006285:Health Planning; D007267:Injections; D007843:Latin America; D008137:Longitudinal Studies; D017258:Medroxyprogesterone Acetate; D008599:Menstruation Disturbances; D008800:Mexico; D009656:North America; D010342:Patient Acceptance of Health Care; D011153:Population; D011157:Population Dynamics; D012102:Reproductive Control Agents; D012106:Research; D012725:Sexual Behavior; D013995:Time; D013997:Time Factors
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D012102:Reproductive Control Agents; D017258:Medroxyprogesterone Acetate
Acceptor Characteristics; Acceptors; Acne; Amenorrhea; Americas; Behavior; Contraception; Contraception Termination; Contraceptive Agents, Female; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Methods; Demographic Factors; Depo-provera--side effects; Dermatitis; Developing Countries; Diseases; Family Planning; Family Planning Programs; Injectables; Latin America; Longitudinal Studies; Longterm Effects; Medroxyprogesterone Acetate; Menstruation Disorders; Mexico; North America; Population; Population Dynamics; Reproductive Control Agents; Research Methodology; Sex Behavior--side effects; Studies; Time Factors